Literature DB >> 12173061

[Clinical and epidemiological data of patients with malignomas of the head and neck].

S Lang1, B Wollenberg, M Dellian, M K Steuer-Vogt, K Schwenzer, W Sautier, M Chucholowski, R Eckel, I Faas, E Wilmes, M Ehrenfeld, W Arnold, E Kastenbauer, D Hölzel.   

Abstract

BACKGROUND: The present study describes clinical and epidemiological data of patients with malignomas of the head and neck documented in the Munich Cancer Register. PATIENTS AND METHODS: Data of head and neck cancer patients treated at four departments of head and neck surgery and one of oral-maxillo-facial surgery in the area of Munich from 1978 up to now are reported.
RESULTS: Incidence and mortality as a function of age, sex, and tumor localization are described in comparison to clinical and epidemiological data as specified in tumor registers of the Saarland and the USA. Moreover, TNM stages, survival, recurrence, and metastasis rates are presented.
CONCLUSION: Based on the documentation of the Munich Cancer Register our study is the first to present a detailed description of clinical and epidemiological data of patients suffering from head and neck malignomas.

Entities:  

Mesh:

Year:  2002        PMID: 12173061     DOI: 10.1055/s-2002-33285

Source DB:  PubMed          Journal:  Laryngorhinootologie        ISSN: 0935-8943            Impact factor:   1.057


  13 in total

1.  The Oral Serine Protease Inhibitor WX-671 - First Experience in Patients with Advanced Head and Neck Carcinoma.

Authors:  Jens E Meyer; Carsten Brocks; Hendrik Graefe; Carola Mala; Natalie Thäns; Markus Bürgle; Annette Rempel; Nicole Rotter; Barbara Wollenberg; Stephan Lang
Journal:  Breast Care (Basel)       Date:  2008-10-16       Impact factor: 2.860

2.  [Laryngeal carcinoma: epidemiology, risk factors and survival].

Authors:  M Pantel; O Guntinas-Lichius
Journal:  HNO       Date:  2012-01       Impact factor: 1.284

Review 3.  [Cell-based strategies for salivary gland regeneration].

Authors:  N Rotter; C Wirz; J Oder; B Wollenberg; R Huss; S Brandau; S Lang; M Bücheler
Journal:  HNO       Date:  2008-03       Impact factor: 1.284

4.  Head and neck cancer in Germany: a site-specific analysis of survival of the Thuringian cancer registration database.

Authors:  Orlando Guntinas-Lichius; Thomas Wendt; Jens Buentzel; Dirk Esser; Peter Lochner; Andreas Mueller; Stefan Schultze-Mosgau; Annelore Altendorf-Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2010-01       Impact factor: 4.553

5.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

6.  Multimodal therapy for synergic inhibition of tumour cell invasion and tumour-induced angiogenesis.

Authors:  Pamela Zengel; Diana Ramp; Brigitte Mack; Stefan Zahler; Alexander Berghaus; Bernd Muehlenweg; Olivier Gires; Suna Schmitz
Journal:  BMC Cancer       Date:  2010-03-11       Impact factor: 4.430

7.  [Treatment results of nasopharyngeal carcinoma in adults].

Authors:  M Jakob; M Manz; S Herberhold; A Schröck; A O H Gerstner; H Schüller; K W G Eichhorn
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

8.  T regulatory type 1 cells in squamous cell carcinoma of the head and neck: mechanisms of suppression and expansion in advanced disease.

Authors:  Christoph Bergmann; Laura Strauss; Yun Wang; Miroslaw J Szczepanski; Stephan Lang; Jonas T Johnson; Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2008-06-15       Impact factor: 12.531

9.  Keratin 8 expression in head and neck epithelia.

Authors:  Christoph Matthias; Brigitte Mack; Alexander Berghaus; Olivier Gires
Journal:  BMC Cancer       Date:  2008-09-22       Impact factor: 4.430

10.  Systemic therapy strategies for head-neck carcinomas: Current status.

Authors:  Thomas K Hoffmann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.